Bristol-Myers Squibb Co
NYSE:BMY

Watchlist Manager
Bristol-Myers Squibb Co Logo
Bristol-Myers Squibb Co
NYSE:BMY
Watchlist
Price: 58.9 USD -0.52% Market Closed
Market Cap: 119.5B USD

Wall Street
Price Targets

BMY Price Targets Summary
Bristol-Myers Squibb Co

Wall Street analysts forecast BMY stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BMY is 60.92 USD with a low forecast of 33.43 USD and a high forecast of 73.5 USD.

Lowest
Price Target
33.43 USD
43% Downside
Average
Price Target
60.92 USD
3% Upside
Highest
Price Target
73.5 USD
25% Upside
Bristol-Myers Squibb Co Competitors:
Price Targets
TORNTPHARM
Torrent Pharmaceuticals Ltd
12% Upside
688513
Chengdu Easton Biopharmaceuticals Co Ltd
32% Upside
REC
Recordati Industria Chimica e Farmaceutica SpA
10% Upside
600267
Zhejiang Hisun Pharmaceutical Co Ltd
23% Downside
1477
Ocumension Therapeutics
51% Upside
ABBOTINDIA
Abbott India Ltd
9% Upside
CAPLIPOINT
Caplin Point Laboratories Ltd
24% Upside

Revenue
Forecast

Revenue Estimate
Bristol-Myers Squibb Co

For the last 8 years the compound annual growth rate for Bristol-Myers Squibb Co's revenue is 12%. The projected CAGR for the next 3 years is -4%.

12%
Past Growth
-4%
Estimated Growth
Estimates Accuracy
0%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Bristol-Myers Squibb Co

For the last 8 years the compound annual growth rate for Bristol-Myers Squibb Co's operating income is 10%. The projected CAGR for the next 3 years is 11%.

10%
Past Growth
11%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Net Income
Forecast

Net Income Estimate
Bristol-Myers Squibb Co

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-54%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BMY's stock price target?
Price Target
60.92 USD

According to Wall Street analysts, the average 1-year price target for BMY is 60.92 USD with a low forecast of 33.43 USD and a high forecast of 73.5 USD.

What is Bristol-Myers Squibb Co's Revenue forecast?
Projected CAGR
-4%

For the last 8 years the compound annual growth rate for Bristol-Myers Squibb Co's revenue is 12%. The projected CAGR for the next 3 years is -4%.

What is Bristol-Myers Squibb Co's Operating Income forecast?
Projected CAGR
11%

For the last 8 years the compound annual growth rate for Bristol-Myers Squibb Co's operating income is 10%. The projected CAGR for the next 3 years is 11%.

Back to Top